Jean W. Wassenaar MD PhD , C. Duncan Smart MD PhD , Daniel J. Fehrenbach PhD , Vineet Agrawal MD PhD , Matthew M. Dungan BS , Niki L. Fortune , Lin Zhong MD PhD , Anna R. Hemnes MD , R. Stokes Peebles Jr. MD , Francis J. Miller Jr. MD , Amanda C. Doran MD PhD , Meena S. Madhur MD PhD
{"title":"Targeting IL-33/ST2 Signaling Alters Cardiac Structure and Function in Hypertensive Heart Disease","authors":"Jean W. Wassenaar MD PhD , C. Duncan Smart MD PhD , Daniel J. Fehrenbach PhD , Vineet Agrawal MD PhD , Matthew M. Dungan BS , Niki L. Fortune , Lin Zhong MD PhD , Anna R. Hemnes MD , R. Stokes Peebles Jr. MD , Francis J. Miller Jr. MD , Amanda C. Doran MD PhD , Meena S. Madhur MD PhD","doi":"10.1016/j.jacbts.2024.09.006","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":"10 1","pages":"Pages 107-109"},"PeriodicalIF":8.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X24003450","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
期刊介绍:
JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.